Segmentation d’images intravasculaires ultrasonores

L'imagerie intravasculaire ultrasonore (IVUS) est une technologie médicale par cathéter qui produit des images de coupe des vaisseaux sanguins. Elle permet de quantifier et d'étudier la morphologie de plaques d'athérosclérose en plus de visualiser la structure des vaisseaux sanguins (lumière, intima, plaque, média et adventice) en trois dimensions. Depuis quelques années, cette méthode d'imagerie est devenue un outil de choix en recherche aussi bien qu'en clinique pour l'étude de la maladie athérosclérotique. L'imagerie IVUS est par contre affectée par des artéfacts associés aux caractéristiques des capteurs ultrasonores, par la présence de cônes d'ombre causés par les calcifications ou des artères collatérales, par des plaques dont le rendu est hétérogène ou par le chatoiement ultrasonore (speckle) sanguin. L'analyse automatisée de séquences IVUS de grande taille représente donc un défi important. Une méthode de segmentation en trois dimensions (3D) basée sur l'algorithme du fast-marching à interfaces multiples est présentée. La segmentation utilise des attributs des régions et contours des images IVUS. En effet, une nouvelle fonction de vitesse de propagation des interfaces combinant les fonctions de densité de probabilité des tons de gris des composants de la paroi vasculaire et le gradient des intensités est proposée. La segmentation est grandement automatisée puisque la lumière du vaisseau est détectée de façon entièrement automatique. Dans une procédure d'initialisation originale, un minimum d'interactions est nécessaire lorsque les contours initiaux de la paroi externe du vaisseau calculés automatiquement sont proposés à l'utilisateur pour acceptation ou correction sur un nombre limité d'images de coupe longitudinale. La segmentation a été validée à l'aide de séquences IVUS in vivo provenant d'artères fémorales provenant de différents sous-groupes d'acquisitions, c'est-à-dire pré-angioplastie par ballon, post-intervention et à un examen de contrôle 1 an suivant l'intervention. Les résultats ont été comparés avec des contours étalons tracés manuellement par différents experts en analyse d'images IVUS. Les contours de la lumière et de la paroi externe du vaisseau détectés selon la méthode du fast-marching sont en accord avec les tracés manuels des experts puisque les mesures d'aire sont similaires et les différences point-à-point entre les contours sont faibles. De plus, la segmentation par fast-marching 3D s'est effectuée en un temps grandement réduit comparativement à l'analyse manuelle. Il s'agit de la première étude rapportée dans la littérature qui évalue la performance de la segmentation sur différents types d'acquisition IVUS. En conclusion, la segmentation par fast-marching combinant les informations des distributions de tons de gris et du gradient des intensités des images est précise et efficace pour l'analyse de séquences IVUS de grandes tailles. Un outil de segmentation robuste pourrait devenir largement répandu pour la tâche ardue et fastidieuse qu'est l'analyse de ce type d'images.Intravascular ultrasound (IVUS) is a catheter based medical imaging technique that produces cross-sectional images of blood vessels. These images provide quantitative assessment of the vascular wall, information about the nature of atherosclerotic lesions as well as the plaque shape and size. Over the past few years, this medical imaging modality has become a useful tool in research and clinical applications, particularly in atherosclerotic disease studies. However, IVUS imaging is subject to catheter ring-down artifacts, missing vessel parts due to calcification shadowing or side-branches, heterogeneously looking plaques and ultrasonic speckle from blood. The automated analysis of large IVUS data sets thus represents an important challenge. A three-dimensional segmentation algorithm based on the multiple interface fast-marching method is presented. The segmentation is based on region and contour features of the IVUS images: a new speed fonction for the interface propagation that combines the probability density functions (PDFs) of the vessel wall components and the intensity gradients is proposed. The segmentation is highly automated with the detection of the lumen boundary that is fully automatic. Minimal interactions are necessary with a novel initialization procedure since initial contours of the external vessel wall border are also computed automatically on a limited number of longitudinal images and then proposed to the user for acceptance or correction. The segmentation method was validated with in-vivo IVUS data sets acquired from femoral arteries. This database contained 3 subgroups: pullbacks acquired before balloon angioplasty, after the intervention and at a 1 year follow-up examination. Results were compared with validation contours that were manually traced by different experts in IVUS image analysis. The lumen and external wall boundaries detected with the fast-marching method are in agreement with the experts' manually traced contours with similarly found area measurements and small point-to-point contour differences. In addition, the 3D fast-marching segmentation method dramatically reduced the analysis time compared to manual tracing. Such a valdiation study, with comparison between pre- and post-intervention data, has never been reported in the IVUS segmentation literature. In conclusion, the fast-marching method combining the information on the gray level distributions and intensity gradients of the images is precise and efficient to analyze large IVUS sequences. It is hoped that the fast-marching method will become a widely used tool for the fastidious and difficult task of IVUS image processing

CHD prenatal screening with fetal echocardiography

Abstract: Background:The benefit of fetal echocardiograms (FE) to detect severe congenital heart diseases (SCHD) in the setting of a normal second-trimester ultrasound is unclear. We aimed to assess whether the increase in SCHD detection rates when FE are performed for risk factors in the setting of a normal ultrasound was clinically significant to justify the resources needed. Methods:This is a multicenter, population-based, retrospective cohort study, including all singleton pregnancies and offspring in Quebec (Canada) between 2007 and 2015. Administrative health care data were linked with FE clinical data to gather information on prenatal diagnosis of CHD, indications for FE, outcomes of pregnancy and offspring, postnatal diagnosis of CHD, cardiac interventions, and causes of death. The difference between the sensitivity to detect SCHD with and without FE for risk factors was calculated using generalized estimating equations with a noninferiority margin of 5 percentage points. Results:A total of 688 247 singleton pregnancies were included, of which 30 263 had at least one FE. There were 1564 SCHD, including 1071 that were detected prenatally (68.5%). There were 12 210 FE performed for risk factors in the setting of a normal second-trimester ultrasound, which led to the detection of 49 additional cases of SCHD over 8 years. FE referrals for risk factors increased sensitivity by 3.1 percentage points (95% CI, 2.3–4.0; P<0.0001 for noninferiority). Conclusions:In the setting of a normal second-trimester ultrasound, adding a FE for risk factors offered low incremental value to the detection rate of SCHD in singleton pregnancies. The current ratio of clinical gains versus the FE resources needed to screen for SCHD in singleton pregnancies with isolated risk factors does not seem favorable. Further studies should evaluate whether these resources could be better allocated to increase SCHD sensitivity at the ultrasound level, and to help decrease heterogeneity between regions, institutions and operator

Limitations of fetal echocardiography screening

Abstract: Background: The effectiveness of screening strategies targeting pregnancies at higher-risk of congenital heart disease (CHD) is reduced by the low prevalence of severe CHD, increasing CHD detection rates by 2nd trimester ultrasound (U/S), and the high proportion of severe CHD in low-risk pregnancies. We aimed to determine in which situations additional screening by fetal echocardiography (FE) would result in a significant increase in sensitivity and a sizable decrease in the false-negative rate of severe CHD. Methods: We simulated the change in the numbers of detected severe CHD cases when a FE is offered to women with a normal 2nd trimester U/S who have a higher risk of bearing a child with CHD, compared to U/S alone. The primary outcome was the increase in sensitivity. Secondary outcomes were the number needed to screen (NNS) and the reduction in the rate of missed cases. Results: For an U/S sensitivity of 60%, the addition of a FE in pregnancies at high-risk of CHD (risk ratio 3.5, range: 2 to 5) increased sensitivity by 2.4 percentage points (1.1 to 7.9). The NNS to detect one additional case of severe CHD was 436 (156 to 952). The rate of additional severe CHD cases detected by FE was 4 per 100,000 pregnancies (2 to 32). Conclusion: The addition of FE to U/S for severe CHD prenatal screening in pregnancies at high-risk of CHD yielded marginal benefits in terms of increased sensitivity and decreased rates of false negatives, at the expense of significant resource utilization

Ultrafast quantitative ultrasound and shear wave elastography imaging of in vivo duck fatty livers

Multi-parametric ultrasound imaging is a promising tool for quantification of nonalcoholic fatty liver disease. In this work, a protocol of plane wave quantitative ultrasound (QUS) and shear wave elastography imaging (SWEI), quasi-simultaneously acquired, dedicated to quantification of liver steatosis on in vivo fatty duck liver is presented. Shear wave velocity was estimated to classify stiffness in duck liver tissue. QUS consisted of local attenuation coefficient slope estimated with Spectral Log Difference method, and coherent-to-diffuse signal ratio computed from homodyned-K parametric maps. After 9 days of feeding, US attenuation reached a maximum and coherent-todiffuse signal ratio reached a minimum. Coupled together, QUS and SWEI promise a strong potential in steatosis monitoring of fatty liver tissue, in ducks or humans